These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20807504)

  • 41. Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords?
    González-Amaro R; Mittelbrunn M; Sánchez-Madrid F
    Immunology; 2005 Nov; 116(3):289-96. PubMed ID: 16236118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DS-70, a novel and potent α
    Dattoli SD; Baiula M; De Marco R; Bedini A; Anselmi M; Gentilucci L; Spampinato S
    Br J Pharmacol; 2018 Oct; 175(20):3891-3910. PubMed ID: 30051467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New 4-Aminoproline-Based Small Molecule Cyclopeptidomimetics as Potential Modulators of α
    Sartori A; Bugatti K; Portioli E; Baiula M; Casamassima I; Bruno A; Bianchini F; Curti C; Zanardi F; Battistini L
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Overview of the α4β1 Integrin and the Potential Therapeutic Role of its Antagonists.
    Ferreira EFB; Silva LB; Cruz JV; Araújo PHF; Kimani NM; Leite FHA; Campos JM; Santos CBR
    Curr Med Chem; 2021; 28(29):5884-5895. PubMed ID: 33596793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4-beta1 and alpha4-beta7 receptor antagonists.
    Sidduri A; Tilley JW; Lou J; Tare N; Cavallo G; Frank K; Pamidimukkala A; Choi DS; Gerber L; Railkar A; Renzetti L
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1026-31. PubMed ID: 23312474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD.
    Vanderslice P; Biediger RJ; Woodside DG; Berens KL; Holland GW; Dixon RA
    Pulm Pharmacol Ther; 2004; 17(1):1-10. PubMed ID: 14643165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of potent and novel alpha4beta1 antagonists using in silico screening.
    Singh J; Van Vlijmen H; Liao Y; Lee WC; Cornebise M; Harris M; Shu IH; Gill A; Cuervo JH; Abraham WM; Adams SP
    J Med Chem; 2002 Jul; 45(14):2988-93. PubMed ID: 12086484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The identification and optimization of orally efficacious, small molecule VLA-4 antagonists.
    Huryn DM; Konradi AW; Ashwell S; Freedman SB; Lombardo LJ; Pleiss MA; Thorsett ED; Yednock T; Kennedy JD
    Curr Top Med Chem; 2004; 4(14):1473-84. PubMed ID: 15544538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha4beta1 integrin affinity changes govern cell adhesion.
    Chigaev A; Zwartz G; Graves SW; Dwyer DC; Tsuji H; Foutz TD; Edwards BS; Prossnitz ER; Larson RS; Sklar LA
    J Biol Chem; 2003 Oct; 278(40):38174-82. PubMed ID: 12844491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of a potent, orally bioavailable pyrimidine VLA-4 antagonist effective in a sheep asthma model.
    Semko CM; Chen L; Dressen DB; Dreyer ML; Dunn W; Farouz FS; Freedman SB; Holsztynska EJ; Jefferies M; Konradi AW; Liao A; Lugar J; Mutter L; Pleiss MA; Quinn KP; Thompson T; Thorsett ED; Vandevert C; Xu YZ; Yednock TA
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1741-3. PubMed ID: 21316228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small molecule antagonists of alpha4 integrins: novel drugs for asthma.
    Lobb RR; Adams SP
    Expert Opin Investig Drugs; 1999 Jul; 8(7):935-45. PubMed ID: 15992095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3D QSAR (COMFA) of a series of potent and highly selective VLA-4 antagonists.
    Singh J; van Vlijmen H; Lee WC; Liao Y; Lin KC; Ateeq H; Cuervo J; Zimmerman C; Hammond C; Karpusas M; Palmer R; Chattopadhyay T; Adams SP
    J Comput Aided Mol Des; 2002 Mar; 16(3):201-11. PubMed ID: 12363218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An alpha4beta1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice.
    Kenyon NJ; Liu R; O'Roark EM; Huang W; Peng L; Lam KS
    Eur J Pharmacol; 2009 Jan; 603(1-3):138-46. PubMed ID: 19103195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists.
    Chigaev A; Wu Y; Williams DB; Smagley Y; Sklar LA
    J Biol Chem; 2011 Feb; 286(7):5455-63. PubMed ID: 21131351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of cell adhesion by affinity and conformational unbending of alpha4beta1 integrin.
    Chigaev A; Waller A; Zwartz GJ; Buranda T; Sklar LA
    J Immunol; 2007 Jun; 178(11):6828-39. PubMed ID: 17513731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-(3-phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists.
    Gutteridge CE; de Laszlo SE; Kamenecka TM; McCauley E; van Riper G; Mumford RA; Kidambi U; Egger LA; Tong S; Hagmann WK
    Bioorg Med Chem Lett; 2003 Mar; 13(5):885-90. PubMed ID: 12617914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The α4β1/EMILIN1 interaction discloses a novel and unique integrin-ligand type of engagement.
    Capuano A; Fogolari F; Bucciotti F; Spessotto P; Nicolosi PA; Mucignat MT; Cervi M; Esposito G; Colombatti A; Doliana R
    Matrix Biol; 2018 Mar; 66():50-66. PubMed ID: 29037761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist.
    Chanteux H; Staelens L; Mancel V; Gerin B; Boucaut D; Prakash C; Nicolas JM
    Drug Metab Dispos; 2015 Sep; 43(9):1381-91. PubMed ID: 26153275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. α
    Li H; Huang SY; Shi FH; Gu ZC; Zhang SG; Wei JF
    Expert Opin Ther Pat; 2018 Dec; 28(12):903-917. PubMed ID: 30444683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and SAR of N-benzoyl-L-biphenylalanine derivatives: discovery of TR-14035, a dual alpha(4)beta(7)/alpha(4)beta(1) integrin antagonist.
    Sircar I; Gudmundsson KS; Martin R; Liang J; Nomura S; Jayakumar H; Teegarden BR; Nowlin DM; Cardarelli PM; Mah JR; Connell S; Griffith RC; Lazarides E
    Bioorg Med Chem; 2002 Jun; 10(6):2051-66. PubMed ID: 11937364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.